Latest Regulatory News

Page 309 of 640
Magellan Financial Group has updated its dividend announcement, correcting the fully franked total dividend to 46.9 cents per share, significantly higher than initially stated. This adjustment reflects a robust payout comprising final, performance fee, and special dividends.
Claire Turing
Claire Turing
20 Aug 2025
WAM Strategic Value reported a near 50% drop in net profit for FY2025 but maintained its fully franked dividend, supported by an 8.6% portfolio gain that outperformed market downturns.
Claire Turing
Claire Turing
20 Aug 2025
Iris Cairns Property Pty Ltd has increased its cash takeover offer for Reef Casino Trust units to A$3.72 per unit, with the Reef Corporate Services Limited board unanimously recommending acceptance. The offer values the trust at approximately A$185.3 million and awaits regulatory approvals.
Victor Sage
Victor Sage
20 Aug 2025
Centaurus Metals Limited has updated the timetable for its $3 million Share Purchase Plan, offering eligible shareholders in Australia and New Zealand shares at $0.36 each with free-attaching options exercisable at $0.50.
Maxwell Dee
Maxwell Dee
20 Aug 2025
Genetic Technologies Limited has emerged from voluntary administration following a strategic asset sale and is now pursuing recapitalisation and acquisitions to restore its market position.
Ada Torres
Ada Torres
20 Aug 2025
Ainsworth Game Technology reported a steady half-year profit of $4.9 million on a 25% revenue increase, driven by strong domestic sales and new product launches, while navigating regional challenges and a looming Novomatic takeover bid.
Victor Sage
Victor Sage
20 Aug 2025
Redcastle Resources has partnered with BML Ventures to fast-track gold production at key deposits while massively expanding its Eastern Goldfields footprint through a strategic tenement acquisition.
Maxwell Dee
Maxwell Dee
20 Aug 2025
Genetic Technologies Limited reports a 36% increase in half-year losses amid voluntary administration, followed by a recapitalisation and sale of core assets. The company pivots towards new financial services acquisitions under fresh leadership.
Ada Torres
Ada Torres
20 Aug 2025
Invion Limited secures a pivotal FDA Orphan Drug Designation for its lead candidate INV043, targeting anal cancer with promising preclinical results and a fast-tracked development path.
Ada Torres
Ada Torres
20 Aug 2025
Invion Limited has disclosed that the US FDA granted Orphan Drug Designation for its lead cancer drug candidate INV043, explaining recent unusual trading activity in its shares. The company confirmed it was unaware of the FDA decision prior to its public release and has now complied with continuous disclosure rules.
Ada Torres
Ada Torres
20 Aug 2025
EV Resources has signed a strategic Memorandum of Understanding with Wogen Resources and Xcelsior Capital Advisors to fund and advance its Los Lirios Antimony Project in Mexico, aiming to establish a 100 tonne-per-day processing plant.
Maxwell Dee
Maxwell Dee
20 Aug 2025
Duxton Farms has received Foreign Investment Review Board approval for its strategic merger and updated its timetable for key shareholder and court approvals, alongside a $4.55 million capital raise.
Ada Torres
Ada Torres
20 Aug 2025